CoreVision

CoreVision (also referred to as ChipLife) is a China-based early-stage neurotechnology company developing invasive brain-computer interface (BCI) systems. The company focuses on designing and engineering implantable neural hardware aimed at enabling direct communication between the brain and external devices.

Its core R&D efforts are centered on advanced neural signal acquisition, implantable device design, and iterative validation through preclinical animal testing. CoreVision is working to improve the reliability, safety, and performance of core BCI devices, with applications spanning medical neurorehabilitation, assistive technologies, and potential future human-machine interaction systems.

The company is currently in an early seed stage, actively investing in core device process validation, iterative experimentation, and team expansion to accelerate development of its invasive neurotechnology platform.

Keywords

brain-computer interface, BCI, invasive neurotechnology, neural implants, neurohardware, medical devices, neural signal processing, brain-machine interface, deep tech, healthtech, neuroengineering, implantable devices, AI neuroscience, China biotech